MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

Clinical trial NCT06097728 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06097728
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Unresectable Pleural Mesothelioma

Start date: 2023-11-09
Primary completion: 2028-11-16
Enrollment: 863

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.